Recurrent Glioblastoma

The Recurrent Glioblastoma pipeline: 9 tracked drugs, 6 approved for this indication.

Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Recurrent Glioblastoma, so this list is not complete.

6 approved / phase 41 Phase 31 Phase 21 preclinical / unstaged

Compare the share prices of listed companies in Recurrent Glioblastoma →

Market size not yet sourced. How markets are sized ↗

The Recurrent Glioblastoma pipeline

← all assets